maintrac

Bayreuth, Germany Acquired By Sobro
Devices for cancer diagnostics are manufactured by Maintrac.

About maintrac

maintrac is a Healthcare company based in Bayreuth (Germany), and was acquired by Sobro in June 2017. Devices for cancer diagnostics are manufactured by Maintrac. maintrac offers products and services including maintrac Cell Counting and Drug Sensitivity Testing. Its focus areas include Traditional Diagnostics. Its legal entity is Pachmann GmbH & Co. KG.

Company details

Maintrac is located in Bayreuth, Germany, where medical devices focused on cancer diagnostics are developed and produced. Operations center on the biotechnology and healthcare sectors, with an emphasis on tools for detecting and monitoring oncology conditions. Manufacturing processes are conducted in-house, and products are distributed across Europe through the companys domain, maintrac.de. Research efforts support advancements in diagnostic accuracy for clinical applications.

  • Headquarters Bayreuth, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    •••• ••••
  • Website maintrac.de
  • Social LinkedIn X Facebook Instagram YouTube
  • Acquired by Sobro (Jun 2017)
  • Legal Name Pachmann Gmbh & Co. Kg
Key Metrics
  • Latest Funding Round
    $55.82K (USD), Grant

    Aug 2016

  • Investors
    EIC Fund

    & 1 more

  • Acquired by
    Sobro

    (Jun 2017)

Products & Services of maintrac

maintrac offers a comprehensive portfolio of products and services, including maintrac Cell Counting and Drug Sensitivity Testing.

maintrac Cell Counting
Diagnostic Services

Quantitative detection of circulating tumor cells is performed for therapy monitoring and observation of residual tumor burden during and after treatment.

Drug Sensitivity Testing
Diagnostic Services

Effectiveness of drugs and cytotoxic agents is tested using circulating tumor cells before and during treatment to inform therapeutic decisions.

Apps and channels of maintrac

its YouTube channel maintrac has 56 subscribers and 30 videos.

maintrac
YouTube 56 subscribers 30 videos Science & Technology
Open channel

Videos from maintrac

The most watched videos on maintrac's YouTube channel, maintrac (56 subscribers). Click a video to play it here.

Assessment of Tumor Aggressiveness and Risk of Recurrence in Cancer Using stemtrac® I Part 1
49 views
Assessment of Tumor Aggressiveness and Risk of Recurrence in Cancer Using stemtrac® I Part 2
44 views
Einschätzung der Tumoraggressivität und des Rezidivrisikos mittels stemtrac® I Teil 1
40 views
maintrac and stemtrac - Answers to the most frequently asked questions I complete
29 views

More on maintrac.

Funding Insights of maintrac

  • Total Rounds 1
  • Last Round Grant — $55,822
  • First Round $55,822

    (Aug 2016)

  • Investors Count 1

All 1 funding rounds of maintrac with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2016$55,822Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in maintrac

maintrac has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include EIC Fund and Sobro.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Entrepreneurs are supported by Sobro for business growth and vision.
sobro.se
Premium access

Investor details for maintrac

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of maintrac

2 dated milestones of maintrac across 1 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $56K.
  2. Exit Acquired by Sobro.

Web traffic of maintrac

The website of maintrac (maintrac.de) receives about 1.6K visits a month.

  • Monthly visits
    1.6K

    ▼ 25.1% vs previous month

Similar websites

Websites whose visitors overlap most with maintrac. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
csn.cancer.org
csn.cancer.org
100%
–
laborpachmann.de
laborpachmann.de
72%
#11,355,595–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about maintrac

maintrac is headquartered in Bayreuth, Germany. It is registered at Bayreuth, Bavaria, Germany.

Maintrac is located in Bayreuth, Germany, where medical devices focused on cancer diagnostics are developed and produced. Operations center on the biotechnology and healthcare sectors, with an emphasis on tools for detecting and monitoring oncology conditions. Manufacturing processes are conducted in-house, and products are distributed across Europe through the companys domain, maintrac.de. Research efforts support advancements in diagnostic accuracy for clinical applications.

maintrac offers maintrac Cell Counting and Drug Sensitivity Testing.

maintrac has 2 investors. Key investors include EIC Fund, and Sobro.

maintrac operates through Pachmann Gmbh & Co. Kg.

Yes. maintrac was acquired by Sobro in June 2017.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available